Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-09-15Clinical Trial Update: A Study Evaluating the Impact of an Educational Program (EDU-MICI) on Patients With Inflammatory Bowel Disease [NA]
Clinical trial update reports the completion of EDU-MICI, an educational program for patients with inflammatory bowel disease, including Cro…
-
CLINICAL_TRIALS trial_result · 2015-09-07Clinical Trial Update: Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis [Phase 4]
Phase 4 trial evaluating whether adding granulocytapheresis to steroids improves outcomes in active steroid-dependent ulcerative colitis; th…
-
CLINICAL_TRIALS research · 2015-08-31Clinical Trial Update: Study of Inflammatory Markers (VNN1) in Crohn Disease and Ulcerative Colitis. [NA]
This document reports an update on a clinical study evaluating the inflammatory marker VNN1 in Crohn's disease and ulcerative colitis.
-
CLINICAL_TRIALS other · 2015-08-28Clinical Trial Update: The Effect of the Multispecies Probiotic Ecologic 825 Versus Placebo in Ulcerative Colitis Patients [NA]
Clinical trial assessing Ecologic 825 probiotic versus placebo in ulcerative colitis; the study status is suspended.
-
CLINICAL_TRIALS withdrawal · 2015-08-24Clinical Trial Update: Genetic Markers as Predictors of Phenotypes in Pediatric Onset Crohn's Disease
The trial evaluating genetic markers as predictors of Crohn's disease phenotypes in pediatric-onset cases has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-17Clinical Trial Update: IBD-OPERA Database, UC Protocol
Clinical trial update for the IBD-OPERA database focusing on the Ulcerative Colitis protocol; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-08-14Clinical Trial Update: A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160) [Phase 2]
A Phase 2 pilot study evaluating GWP42003 for symptomatic treatment of Ulcerative Colitis has completed with results posted in 2015.
-
FDA label_change · 2015-08-05FDA Approved: SIMPONI ARIA — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for Simponi Aria (golimumab) filed by Janssen Biotech, Inc., resulting in changes to the product lab…
-
FDA approval · 2015-08-05FDA Approved: PENTASA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Pentasa (mesalamine) from Takeda Pharmaceuticals America, resulting in updated labeling for …
-
CLINICAL_TRIALS research · 2015-07-30Clinical Trial Update: Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease
A completed clinical trial examined the prevalence of cytomegalovirus, Epstein-Barr virus, and human herpesvirus-6 in inflammatory bowel dis…
-
CLINICAL_TRIALS trial_result · 2015-07-09Clinical Trial Update: Safety and Pharmacokinetics of MMX Mesalamine in Children and Adolescents With Ulcerative Colitis [Phase 1]
Phase 1 trial update on safety and pharmacokinetics of MMX Mesalamine in children and adolescents with Ulcerative Colitis completed with res…
-
CLINICAL_TRIALS research · 2015-07-03Clinical Trial Update: Study of the Pharmacokinetics of Golimumab in Moderate to Severe Ulcerative Colitis
This entry describes a pharmacokinetics study of golimumab in adults with moderate to severe ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2015-06-29Clinical Trial Update: Efficacy of Gralise® for Chronic Pelvic Pain [Phase 4]
Phase 4 trial evaluating Gralise (gabapentin ER) for chronic pelvic pain was terminated, with results posted in 2015.
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis [Phase 2]
A Phase 2 induction and maintenance trial evaluating BMS-936557 for moderate-to-severe ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-23Clinical Trial Update: Assessment of Photopill Capsule Treatment for Safety and Feasibility in Ulcerative Proctitis [Phase 2]
A Phase 2 trial evaluating the safety and feasibility of the Photopill Capsule for ulcerative proctitis (a form of ulcerative colitis) has c…
-
FDA approval · 2015-06-19FDA Approved: XELJANZ — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approved a supplemental application for XELJANZ (tofacitinib) submitted by Pfizer Laboratories Div Pfizer Inc. The approval updates the …
-
CLINICAL_TRIALS research · 2015-06-09Clinical Trial Update: A Study to Determine Whether Urinary PGE-M Levels Correlate With Ulcerative Colitis Disease [NA]
A Vanderbilt University–led clinical study is evaluating whether urinary PGE-M levels correlate with disease activity in ulcerative colitis …
-
FDA approval · 2015-06-08FDA Approved: BALSALAZIDE DISODIUM — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for balsalazide disodium filed by Apotex Corp., confirming regulatory approval for this generic prod…
-
FDA approval · 2015-06-03FDA Approved: BUDESONIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for budesonide submitted by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: Ulcerative Colitis and Vitamin D Supplementation [Phase 1, Phase 2]
A clinical trial evaluating vitamin D supplementation for ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-06-02Clinical Trial Update: Study of Participants With Crohn's Disease and Ulcerative Colitis in Eastern Europe, Middle East, and North Africa (P08166)
A clinical trial (P08166) sponsored by Merck Sharp & Dohme LLC for Crohn's disease and ulcerative colitis has been withdrawn.
-
CLINICAL_TRIALS research · 2015-05-29Clinical Trial Update: Early Serum Infliximab Levels in Severe Ulcerative Colitis. [Phase 1]
Phase 1 clinical trial update on infliximab levels in severe ulcerative colitis. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-05-22Clinical Trial Update: "Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial" [Phase 4]
Phase 4 trial comparing the infliximab biosimilar Inflectra to Remicade in inflammatory bowel disease patients in remission; current status/…
-
CLINICAL_TRIALS research · 2015-05-15Clinical Trial Update: Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis [Phase 1, Phase 2]
An update on a Phase 1/Phase 2 clinical trial evaluating human umbilical-cord-derived mesenchymal stem cell therapy for active ulcerative co…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis [Phase 2, Phase 3]
A Phase 2/3 clinical trial evaluating the efficacy and mechanism of fecal microbiota transplantation for treating ulcerative colitis.